Flow studies in close-coupled ventral nozzles for STOVL aircraft

Flow in a generic ventral nozzle system was studied experimentally and analytically with the PARC3D computational fluid dynamics program in order to evaluate the program's ability to predict system performance and internal flow patterns. A generic model of a tailpipe with a rectangular ventral nozzle, about 1/3 of full size, was tested with unheated air at steady state pressure ratios up to 4.0. The end of the tailpipe was closed to simulate a blocked exhaust nozzle. Flow behavior into and through the ventral duct is discussed and illustrated with paint streak flow visualization photographs. PARC3D graphic images are shown for comparison with the experimental photographs. The program successfully predicted internal flow patterns; it also computed thrust and discharge coefficients within 1 pct. of measured values

Experimental and analytical study of close-coupled ventral nozzles for ASTOVL aircraft

Flow in a generic ventral nozzle system was studied experimentally and analytically with a block version of the PARC3D computational fluid dynamics program (a full Navier-Stokes equation solver) in order to evaluate the program's ability to predict system performance and internal flow patterns. For the experimental work a one-third-size model tailpipe with a single large rectangular ventral nozzle mounted normal to the tailpipe axis was tested with unheated air at steady-state pressure ratios up to 4.0. The end of the tailpipe was closed to simulate a blocked exhaust nozzle. Measurements showed about 5 1/2 percent flow-turning loss, reasonable nozzle performance coefficients, and a significant aftward axial component of thrust due to flow turning loss, reasonable nozzle performance coefficients, and a significant aftward axial component of thrust due to flow turning more than 90 deg. Flow behavior into and through the ventral duct is discussed and illustrated with paint streak flow visualization photographs. For the analytical work the same ventral system configuration was modeled with two computational grids to evaluate the effect of grid density. Both grids gave good results. The finer-grid solution produced more detailed flow patterns and predicted performance parameters, such as thrust and discharge coefficient, within 1 percent of the measured values. PARC3D flow visualization images are shown for comparison with the paint streak photographs. Modeling and computational issues encountered in the analytical work are discussed

The Stokes boundary layer for a thixotropic or antithixotropic fluid

We present a mathematical investigation of the oscillatory boundary layer (‘Stokes layer’) in a semi-infinite fluid bounded by an oscillating wall (the socalled ‘Stokes problem’), when the fluid has a thixotropic or antithixotropic rheology. We obtain asymptotic solutions in the limit of small-amplitude oscillations, and we use numerical integration to validate the asymptotic solutions and to explore the behaviour of the system for larger-amplitude oscillations. The solutions that we obtain differ significantly from the classical solution for a Newtonian fluid. In particular, for antithixotropic fluids the velocity reaches zero at a finite distance from the wall, in contrast to the exponential decay for a thixotropic or a Newtonian fluid. For small amplitudes of oscillation, three regimes of behaviour are possible: the structure parameter may take values defined instantaneously by the shear rate, or by a long-term average; or it may behave hysteretically. The regime boundaries depend on the precise specification of structure build-up and breakdown rates in the rheological model, illustrating the subtleties of complex fluid models in non-rheometric settings. For larger amplitudes of oscillation the dominant behaviour is hysteretic. We discuss in particular the relationship between the shear stress and the shear rate at the oscillating wall

Are there functional consequences of a reduction in selenium intake in UK subjects?

Dietary Se levels in the UK have fallen over the last 20 years and recent surveys indicate that average Se intakes are 30-40 microg/d, which is well below the current UK reference nutrient intake for adult men (75 microg/d) or women (60 microg/d). Functional consequences of this decline have not been recognised, although epidemiological data suggest it may contribute to increased risk of infections and incidence of some cancers. Previous data have indicated that biochemical changes in Se-dependent proteins occur in otherwise healthy UK subjects given small Se supplements. The current studies have focused on the effect of small Se supplements on the immune response since there is evidence of specific interactions between Se intake and viral replication, and since the potential anti-cancer effects of Se may be mediated by non-antioxidant effects of Se such as changes in immune function. Data indicate that subjects given small Se supplements (50 or 100 microg Se/d) have changes in the activity of Se-dependent enzymes and evidence of improved immune function and clearance of an administered live attenuated virus in the form of poliovirus vaccine. Responses of individual subjects to Se supplements are variable, and current work is evaluating potential explanations for this variability, including genetic variability and pre-existing Se status

HAGE, a cancer/testis antigen expressed at the protein level in a variety of cancers

The search for novel tumour antigens that are either uniquely expressed or over-expressed in a wide variety of tumours is still ongoing. Because of their expression in a broad spectrum of cancers and limited expression in normal tissues, cancer/testis antigens are considered to be potentially reliable targets for immunotherapy of cancer in general. The helicase antigen HAGE has been identified as a cancer/testis antigen. However, little is known about its expression in normal and cancer tissues. Using a newly developed antibody against HAGE, specific staining of its expression by immunohistochemistry was validated and optimised on murine tumours transfected to express the HAGE protein. The antibody was subsequently used to determine HAGE expression in normal human and cancer tissue microarrays. HAGE protein expression was confirmed in 75% (12/16) of carcinomas as compared to normal tissues, which either did not express HAGE at all or expressed HAGE at very low levels with the exception of testis. Interestingly, discrepancies were also found between mRNA analysis by real time quantitative PCR (RT-qPCR) and protein analysis by immunohistochemistry, emphasising the need to validate the expression of cancer/testis antigens at the protein level prior to the development of new vaccine strategies. HAGE is therefore proposed to be a valid candidate for designing a broad spectrum vaccine against cancer

Processes underlying the nutritional programming of embryonic development by iron deficiency in the rat

Peer reviewedPublisher PD